KAMADA LTD (KMDA) Stock Fundamental Analysis
NASDAQ:KMDA - Nasdaq - IL0010941198 - Common Stock - Currency: USD
Taking everything into account, KMDA scores 6 out of 10 in our fundamental rating. KMDA was compared to 568 industry peers in the Biotechnology industry. KMDA scores excellent on profitability, but there are some minor concerns on its financial health. KMDA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year KMDA was profitable.
KMDA had a positive operating cash flow in the past year.
In multiple years KMDA reported negative net income over the last 5 years.
Of the past 5 years KMDA 4 years had a positive operating cash flow.
1.2 Ratios
KMDA's Return On Assets of 3.88% is amongst the best of the industry. KMDA outperforms 93.13% of its industry peers.
KMDA's Return On Equity of 5.57% is amongst the best of the industry. KMDA outperforms 93.66% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.91%, KMDA belongs to the top of the industry, outperforming 93.66% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for KMDA is significantly below the industry average of 14.25%.
The 3 year average ROIC (2.98%) for KMDA is below the current ROIC(4.91%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.88% | ||
| ROE | 5.57% | ||
| ROIC | 4.91% |
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
1.3 Margins
KMDA's Profit Margin of 8.99% is amongst the best of the industry. KMDA outperforms 93.49% of its industry peers.
KMDA's Profit Margin has declined in the last couple of years.
KMDA has a better Operating Margin (12.46%) than 94.37% of its industry peers.
KMDA's Operating Margin has declined in the last couple of years.
The Gross Margin of KMDA (43.47%) is better than 75.18% of its industry peers.
KMDA's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.46% | ||
| PM (TTM) | 8.99% | ||
| GM | 43.47% |
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
2. Health
2.1 Basic Checks
KMDA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for KMDA remains at a similar level compared to 1 year ago.
The number of shares outstanding for KMDA has been increased compared to 5 years ago.
KMDA has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.94 indicates that KMDA is not a great score, but indicates only limited risk for bankruptcy at the moment.
KMDA has a better Altman-Z score (2.94) than 77.64% of its industry peers.
The Debt to FCF ratio of KMDA is 0.30, which is an excellent value as it means it would take KMDA, only 0.30 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.30, KMDA belongs to the top of the industry, outperforming 96.30% of the companies in the same industry.
KMDA has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
KMDA has a worse Debt to Equity ratio (0.04) than 60.92% of its industry peers.
Although KMDA does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.3 | ||
| Altman-Z | 2.94 |
ROIC/WACC0.55
WACC8.84%
2.3 Liquidity
KMDA has a Current Ratio of 3.73. This indicates that KMDA is financially healthy and has no problem in meeting its short term obligations.
KMDA has a Current ratio of 3.73. This is comparable to the rest of the industry: KMDA outperforms 44.54% of its industry peers.
A Quick Ratio of 2.14 indicates that KMDA has no problem at all paying its short term obligations.
The Quick ratio of KMDA (2.14) is worse than 72.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.73 | ||
| Quick Ratio | 2.14 |
3. Growth
3.1 Past
KMDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.33%, which is quite impressive.
The earnings per share for KMDA have been decreasing by -13.60% on average. This is quite bad
The Revenue has grown by 12.94% in the past year. This is quite good.
KMDA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.82% yearly.
EPS 1Y (TTM)73.33%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%-22.22%
Revenue 1Y (TTM)12.94%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%7.06%
3.2 Future
Based on estimates for the next years, KMDA will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.50% on average per year.
Based on estimates for the next years, KMDA will show a quite strong growth in Revenue. The Revenue will grow by 8.74% on average per year.
EPS Next Y13.77%
EPS Next 2Y21.56%
EPS Next 3Y19.5%
EPS Next 5YN/A
Revenue Next Year11.6%
Revenue Next 2Y10.42%
Revenue Next 3Y8.74%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
KMDA is valuated quite expensively with a Price/Earnings ratio of 25.00.
Compared to the rest of the industry, the Price/Earnings ratio of KMDA indicates a rather cheap valuation: KMDA is cheaper than 95.07% of the companies listed in the same industry.
KMDA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.29.
With a Price/Forward Earnings ratio of 21.97, KMDA is valued on the expensive side.
Based on the Price/Forward Earnings ratio, KMDA is valued cheaper than 94.19% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.08, KMDA is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25 | ||
| Fwd PE | 21.97 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KMDA indicates a rather cheap valuation: KMDA is cheaper than 97.71% of the companies listed in the same industry.
97.89% of the companies in the same industry are more expensive than KMDA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.14 | ||
| EV/EBITDA | 9.05 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of KMDA may justify a higher PE ratio.
A more expensive valuation may be justified as KMDA's earnings are expected to grow with 19.50% in the coming years.
PEG (NY)1.82
PEG (5Y)N/A
EPS Next 2Y21.56%
EPS Next 3Y19.5%
5. Dividend
5.1 Amount
KMDA has a Yearly Dividend Yield of 3.08%.
KMDA's Dividend Yield is rather good when compared to the industry average which is at 6.61. KMDA pays more dividend than 98.94% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.57, KMDA has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.08% |
5.2 History
KMDA does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y21.56%
EPS Next 3Y19.5%
NASDAQ:KMDA (4/17/2025, 8:00:02 PM)
6.5
+0.15 (+2.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners11.62%
Inst Owner Change0%
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap373.81M
Analysts84.44
Price Target15.05 (131.54%)
Short Float %0.11%
Short Ratio0.14
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.08% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.81%
Min EPS beat(2)2.94%
Max EPS beat(2)28.68%
EPS beat(4)3
Avg EPS beat(4)8.85%
Min EPS beat(4)-34.64%
Max EPS beat(4)38.4%
EPS beat(8)6
Avg EPS beat(8)5.89%
EPS beat(12)8
Avg EPS beat(12)-32.21%
EPS beat(16)8
Avg EPS beat(16)-102.42%
Revenue beat(2)0
Avg Revenue beat(2)-1.53%
Min Revenue beat(2)-3.06%
Max Revenue beat(2)0%
Revenue beat(4)1
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)4.89%
Revenue beat(8)2
Avg Revenue beat(8)-1.48%
Revenue beat(12)3
Avg Revenue beat(12)-1.91%
Revenue beat(16)4
Avg Revenue beat(16)-0.87%
PT rev (1m)0.57%
PT rev (3m)-4.84%
EPS NQ rev (1m)1.24%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-16.35%
EPS NY rev (3m)-7.45%
Revenue NQ rev (1m)1.01%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.3%
Revenue NY rev (3m)5.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25 | ||
| Fwd PE | 21.97 | ||
| P/S | 2.32 | ||
| P/FCF | 10.14 | ||
| P/OCF | 7.85 | ||
| P/B | 1.44 | ||
| P/tB | 2.94 | ||
| EV/EBITDA | 9.05 |
EPS(TTM)0.26
EY4%
EPS(NY)0.3
Fwd EY4.55%
FCF(TTM)0.64
FCFY9.86%
OCF(TTM)0.83
OCFY12.73%
SpS2.8
BVpS4.51
TBVpS2.21
PEG (NY)1.82
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.88% | ||
| ROE | 5.57% | ||
| ROCE | 6.21% | ||
| ROIC | 4.91% | ||
| ROICexc | 6.48% | ||
| ROICexgc | 14.11% | ||
| OM | 12.46% | ||
| PM (TTM) | 8.99% | ||
| GM | 43.47% | ||
| FCFM | 22.9% |
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.78%
ROICexc(5y)N/A
ROICexgc(3y)8.93%
ROICexgc(5y)N/A
ROCE(3y)3.78%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-12.12%
ROICexc growth 3YN/A
ROICexc growth 5Y-24.72%
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
F-Score7
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.3 | ||
| Debt/EBITDA | 0.28 | ||
| Cap/Depr | 77.78% | ||
| Cap/Sales | 6.67% | ||
| Interest Coverage | 33.76 | ||
| Cash Conversion | 140.57% | ||
| Profit Quality | 254.83% | ||
| Current Ratio | 3.73 | ||
| Quick Ratio | 2.14 | ||
| Altman-Z | 2.94 |
F-Score7
WACC8.84%
ROIC/WACC0.55
Cap/Depr(3y)51.63%
Cap/Depr(5y)66.68%
Cap/Sales(3y)4.57%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.33%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%-22.22%
EPS Next Y13.77%
EPS Next 2Y21.56%
EPS Next 3Y19.5%
EPS Next 5YN/A
Revenue 1Y (TTM)12.94%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%7.06%
Revenue Next Year11.6%
Revenue Next 2Y10.42%
Revenue Next 3Y8.74%
Revenue Next 5YN/A
EBIT growth 1Y99.2%
EBIT growth 3YN/A
EBIT growth 5Y-2.54%
EBIT Next Year111.37%
EBIT Next 3Y35.35%
EBIT Next 5YN/A
FCF growth 1Y2500.91%
FCF growth 3YN/A
FCF growth 5Y7.84%
OCF growth 1Y1002.99%
OCF growth 3YN/A
OCF growth 5Y11.54%